NCT03367078

Brief Summary

The present observational study is aimed at reporting the short-, mid- and long-term outcomes of patients with Disorder of Consciousness (DOC), in Vegetative State (VS) or Minimally Conscious State (MCS), due to a severe Acquired Brain Injury (sABI), after repeated treatments with anodal Transcranial Direct Current Stimulation (tDCS) on Left Dorsolateral Prefrontal Cortex (L-DLPFC), to stimulate recovery of consciousness. The results obtained will also be compared with those of a historical control cohort, before the introduction of tDCS, matched for demographic and clinical characteristics.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 8, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

June 18, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

August 14, 2020

Status Verified

August 1, 2020

Enrollment Period

2 years

First QC Date

December 4, 2017

Last Update Submit

August 12, 2020

Conditions

Keywords

tDCStranscranial direct current stimulationacquired brain injurycomavigilance

Outcome Measures

Primary Outcomes (2)

  • Change in coma recovery in the tDCS cohort (short- and mid-term outcomes)

    Assessment by Coma Recovery Scale-Revised (CRS-R) (on-line, where tDCS is administered)

    Baseline (initial visit); tDCS session 5 (1 week); tDCS closing session 10 (2 weeks); follow-up 1 (1 week after tDCS closing session 10); follow-up 2 (3 months after tDCS closing session 10)

  • Change in cognitive functioning level in the tDCS cohort (short- and mid-term outcomes)

    Assessment by Levels of Cognitive Functioning Scale (LCF) (off-line, i.e. where tDCS is administered, immediately after tDCS session)

    Baseline (initial visit); tDCS session 5 (1 week); tDCS closing session 10 (2 weeks); follow-up 1 (1 week after tDCS closing session 10); follow-up 2 (3 months after tDCS closing session 10)

Secondary Outcomes (7)

  • Change in coma recovery in the tDCS cohort (long-term outcome)

    Baseline (initial visit); follow-up 3 (6 months after tDCS closing session 10)

  • Change in cognitive functioning level in the tDCS cohort (long-term outcome)

    Baseline (initial visit); follow-up 3 (6 months after tDCS closing session 10)

  • Change in disability level in the tDCS cohort (short-, mid- and long-term follow-up)

    Baseline (initial visit); follow-up 1 (1 week after tDCS closing session 10); follow-up 2 (3 months after tDCS closing session 10); follow-up 3 (6 months after closing session 10)

  • Change in electroencephalography pattern in the tDCS cohort

    Baseline (initial visit); tDCS tDCS closing session 10 (2 weeks)

  • Change in coma recovery between the tDCS cohort and the Historical control cohort

    Baseline (initial visit); 3 months; 6 months

  • +2 more secondary outcomes

Study Arms (2)

tDCS cohort

DOC patients treated according to usual care, plus anodal tDCS (prospective cohort)

Device: Anodal tDCSOther: Usual care

Historical control cohort

DOC patients treated according to usual care only (retrospective cohort of patients matched for demographic and clinical characteristics, admitted at the Montecatone Rehabilitation Institute no more than 3 years before the introduction of tDCS)

Other: Usual care

Interventions

Anodal tDCS, on L-DLPFC area, is started 2 weeks after admission to the sABI Operative Unit with: one session per day (in the morning), possibly for 5 consecutive days per week (from Monday to Friday), for 2 consecutive weeks. Each tDCS session lasts 20 minutes. Current intensity is 1 mA during the first week, 2 mA in the second week

tDCS cohort

Usual care of DOC patients

Historical control cohorttDCS cohort

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Consecutive DOC patients admitted to the sABI Operative Unit of the Montecatone Rehabilitation Institute

You may qualify if:

  • patients with Disorder of Consciousness, VS (= LCF 2) or MCS (= LCF 3), due to sABI;
  • any etiology, with the exception of extensive haemorrhagic lesions;
  • stable clinical conditions.

You may not qualify if:

  • presence of implanted devices (e.g. pacemakers, intrathecal infusers);
  • presence of metallic brain implants (clips) or intracranial implants;
  • presence of extensive craniotomy involving the area of application of tDCS;
  • history of epileptic seizure;
  • mechanical ventilation in place;
  • history of psychotic disorders;
  • severe neurodegenerative pathology;
  • pharmacotherapy with Na+ or Ca++ channel blockers (e.g. Carbamazepine) or with N-Methyl-D-aspartate (NMDA) receptor antagonists (e.g. Dextromethorphan);
  • pregnancy in progress.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montecatone Rehabilitation Institute S.p.A.

Imola, BO, 40026, Italy

Location

MeSH Terms

Conditions

Consciousness DisordersBrain InjuriesPersistent Vegetative StateCognitive DysfunctionComa

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersBrain DiseasesCentral Nervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesBrain Damage, ChronicUnconsciousnessCognition Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Angela Morreale, MD

    Montecatone Rehabilitation Institute S.p.A.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2017

First Posted

December 8, 2017

Study Start

June 18, 2018

Primary Completion

June 30, 2020

Study Completion

June 30, 2020

Last Updated

August 14, 2020

Record last verified: 2020-08

Locations